Archive Newsletter

11. 03.21.25 -- Advancements In The Global Clinical Trial Landscape 3/21/2025

    03/21/25 Advancing RNA Newsletter

12. 03.19.25 -- DNA Quality For IVT: What Do We (Really) Know? 3/19/2025
    03/19/25 Advancing RNA Newsletter
13. 03.18.25 -- Exploring The Benefits Of Novel Nucleases In CRISPR Therapies 3/18/2025

    03/18/25 Advancing RNA Newsletter

14. 03.12.25 -- How Are The Costs Of mRNA-LNP Manufacturing Evolving? 3/12/2025
    03/12/25 Advancing RNA Newsletter
15. 03.05.25 -- The Latest & Greatest Innovations In mRNA-LNP production 3/5/2025
    03/05/25 Advancing RNA Newsletter
16. 02.26.25 -- IP Considerations For Early-Stage mRNA Therapeutics Development 2/26/2025
    02/26/25 Advancing RNA Newsletter
17. 02.24.25 -- How To Best Optimize mRNA Production Workflows 2/24/2025
    02/24/25 Advancing RNA Newsletter
18. 02.19.25 -- A Primer On The RNA Patent Landscape 2/19/2025
    02/19/25 Advancing RNA Newsletter
19. 02.12.25 -- FAQs – RNA Therapies – Global Clinical Trials Landscape (2024) 2/12/2025
    02/12/25 Advancing RNA Newsletter
20. 02.05.25 -- Go From Batch To Continuous RNA Purification With mAb Equipment & QBD 2/5/2025
    02/05/25 Advancing RNA Newsletter